Annual Cash & Cash Equivalents
$21.94 M
-$28.78 M-56.74%
31 December 2023
Summary:
NuCana annual cash & cash equivalents is currently $21.94 million, with the most recent change of -$28.78 million (-56.74%) on 31 December 2023. During the last 3 years, it has fallen by -$97.11 million (-81.57%). NCNA annual cash & cash equivalents is now -81.57% below its all-time high of $119.05 million, reached on 31 December 2020.NCNA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$14.72 M
-$1.52 M-9.39%
30 June 2024
Summary:
NuCana quarterly cash and cash equivalents is currently $14.72 million, with the most recent change of -$1.52 million (-9.39%) on 30 June 2024. Over the past year, it has dropped by -$7.00 million (-32.23%). NCNA quarterly cash and cash equivalents is now -88.63% below its all-time high of $129.51 million, reached on 30 September 2020.NCNA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NCNA Cash And Cash Equivalents Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -56.7% | -32.2% |
3 y3 years | -81.6% | -84.6% |
5 y5 years | -77.5% | -79.4% |
NCNA Cash And Cash Equivalents High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -81.6% | at low | -84.6% | at low |
5 y | 5 years | -81.6% | at low | -88.6% | at low |
alltime | all time | -81.6% | +5.0% | -88.6% | at low |
NuCana Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
June 2024 | - | $14.72 M(-9.4%) |
Mar 2024 | - | $16.25 M(-26.0%) |
Dec 2023 | $21.94 M(-56.7%) | $21.94 M(+1.0%) |
Sept 2023 | - | $21.72 M(-30.1%) |
June 2023 | - | $31.08 M(-19.0%) |
Mar 2023 | - | $38.40 M(-24.3%) |
Dec 2022 | $50.72 M(-37.6%) | $50.72 M(-10.5%) |
Sept 2022 | - | $56.67 M(+0.4%) |
June 2022 | - | $56.43 M(-18.3%) |
Mar 2022 | - | $69.04 M(-15.1%) |
Dec 2021 | $81.33 M(-31.7%) | $81.33 M(-14.7%) |
Sept 2021 | - | $95.37 M(-6.1%) |
June 2021 | - | $101.61 M(-6.0%) |
Mar 2021 | - | $108.07 M(-9.2%) |
Dec 2020 | $119.05 M | $119.05 M(-8.1%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2020 | - | $129.51 M(+120.1%) |
June 2020 | - | $58.84 M(-0.1%) |
Mar 2020 | - | $58.88 M(-13.6%) |
Dec 2019 | $68.13 M(-30.2%) | $68.13 M(-4.6%) |
Sept 2019 | - | $71.41 M(-13.5%) |
June 2019 | - | $82.59 M(-9.4%) |
Mar 2019 | - | $91.18 M(-6.6%) |
Dec 2018 | $97.67 M(-16.6%) | $97.67 M(-4.3%) |
Sept 2018 | - | $102.08 M(-4.2%) |
June 2018 | - | $106.51 M(-6.6%) |
Mar 2018 | - | $114.00 M(-2.7%) |
Dec 2017 | $117.17 M(+377.1%) | $117.17 M(+465.8%) |
June 2017 | - | $20.71 M(-15.7%) |
Dec 2016 | $24.56 M(+17.5%) | $24.56 M |
Dec 2015 | $20.91 M | - |
FAQ
- What is NuCana annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for NuCana?
- What is NuCana annual cash & cash equivalents year-on-year change?
- What is NuCana quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for NuCana?
- What is NuCana quarterly cash and cash equivalents year-on-year change?
What is NuCana annual cash & cash equivalents?
The current annual cash & cash equivalents of NCNA is $21.94 M
What is the all time high annual cash & cash equivalents for NuCana?
NuCana all-time high annual cash & cash equivalents is $119.05 M
What is NuCana annual cash & cash equivalents year-on-year change?
Over the past year, NCNA annual cash & cash equivalents has changed by -$28.78 M (-56.74%)
What is NuCana quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of NCNA is $14.72 M
What is the all time high quarterly cash and cash equivalents for NuCana?
NuCana all-time high quarterly cash and cash equivalents is $129.51 M
What is NuCana quarterly cash and cash equivalents year-on-year change?
Over the past year, NCNA quarterly cash and cash equivalents has changed by -$7.00 M (-32.23%)